Earnings Scheduled For February 14, 2022
Companies Reporting Before The Bell
• Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million.
Roivant Sciences Reports Licensing Of Splicing Modulator
Roivant will develop RVT-2001 for the treatment of transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes
Roivant JPM presentation scheduled for Monday, January 10, at 2:15 p.m. ET
BASEL,
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
BioCardia (NASDAQ:BCDA) shares rose 29.91% to $2.91 during Wednesday's after-market session. At the close, BioCardia's trading volume reached 793.9K shares. This is 471.05% of its average volume over the last 100 days. The company's market cap stands at $49.0 million.
65 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.
Goldman Sachs Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $15
Goldman Sachs analyst Corinne Jenkins initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Price Target of $15.
50 Biggest Movers From Friday
Gainers
SigmaTron International, Inc. (NASDAQ: SGMA) jumped 84.7% to settle at $14.94 on Friday after the company reported Q2 EPS and sales results were higher year over year.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 7.38% to $1.6 during Thursday's after-market session. The market value of their outstanding shares is at $42.5 million.
